Company intelligence / Profile preview
Avivo Biomedical Inc.
Vancouver, British Columbia, Canadaavivobio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company is in preclinical development of its proprietary enzyme system that converts blood type A to type O (universal donor type) for both organ transplantation and blood transfusion applications.
- Therapeutic areas
- Hematology
- Modalities
- Enzymatic conversion technology
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Mayo Clinic
Beyond the preview
Go deeper on Avivo Biomedical Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avivo Biomedical Inc..